Clinical trial
Cetuximab, Cisplatin, and Radiotherapy in Women With Locally Advanced Cervical…
NCT00292955 · University of Virginia, Other · Unknown status
Key facts
| NCT number | NCT00292955 |
|---|---|
| Title | Cetuximab, Cisplatin, and Radiotherapy in Women With Locally Advanced Cervical Carcinoma |
| Official title | An Exploratory Pharmacogenomic Study of Neoadjuvant Cetuximab Followed by Cisplatin, Radiotherapy, and Cetuximab in Women With Newly Diagnosed Locally Advanced or Metastatic Cervical Carcinoma |
| Lead sponsor | University of Virginia, Other |
| Collaborators | Bristol-Myers Squibb Industry Eli Lilly and Company Washington University School of Medicine |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cancer of the Cervix |
| Intervention type | Drug |
| Interventions | Cetuximab |
| Enrollment | 30 |
| Start date | Feb 1, 2006 |
| Primary completion | Feb 1, 2012 |
| First posted | Feb 16, 2006 |
| Last update posted | May 30, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: